Alcohol-induced chronic pancreatitis

ALCOPANCCHRON

alcoholic pancreatitis: Acute or chronic inflammation of the pancreas due to excessive alcohol drinking. Alcoholic pancreatitis usually presents as an acute episode but it is a chronic progressive disease in alcoholics.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K86.00, K86.01, K86.08 Hospital discharge: ICD-9 — 5771C\|5771D Cause of death: ICD-10 — K86.00, K86.01, K86.08 Cause of death: ICD-9 — 5771C\|5771D 2 out of 7 registries used, show all original rules.	2456
4. Check minimum number of events None	2456
5. Include endpoints None	2456
6. Filter based on genotype QC (FinnGen only)	2456

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	ALCOPANCCHRON
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K860
HD_ICD_9	5771C\|5771D
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K860
COD_ICD_9	5771C\|5771D
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Alcohol-induced chronic pancreatitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	26565	4781	21551
Only index persons	20455	3883	16572
Unadjusted period prevalence (%)
Whole population	0.52	0.14	0.60
Only index persons	0.54	0.14	0.63
Median age at first event (years)
Whole population	49.32	50.76	48.95
Only index persons	49.19	50.78	48.82

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2456	507	1949
Unadjusted period prevalence (%)	0.72	0.17	0.86
Median age at first event (years)	50.92	50.46	51.04

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2214: Matched controls
22135

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

16384.0

323.0

1874

K86.1

ICD-10 Finland

Other chronic pancreatitis

132.2

323.0

436

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

167.4

323.0

376

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

14.6

323.0

862

926

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

+∞

323.0

594

K85

ICD-10 Finland

Acute pancreatitis

101.6

323.0

718

104

A09AA02

ATC

multienzymes (lipase, protease etc.)

39.1

323.0

447

142

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

52.0

323.0

557

142

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

46.1

310.5

383

100

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

5.5

297.2

1280

4397

K86.3

ICD-10 Finland

Pseudocyst of pancreas

145.5

287.7

302

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

+∞

275.9

259

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

51.6

235.4

284

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

15.5

225.5

388

300

N07BB01

ATC

disulfiram; oral

9.5

220.3

491

644

JN3BD

NOMESCO Finland

Extensive abdominal CT

6.6

215.4

633

1262

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

5.8

203.4

671

1536

R10.1

ICD-10 Finland

Pain localized to upper abdomen

5.4

195.3

691

1707

103

Kela drug reimbursment

Diabetes, insulin-treated

4.0

189.4

1063

4138

F10.25

ICD-10 Finland

Alcohol dependence continuous use

17.8

179.7

290

186

A10AE04

ATC

insulin glargine; parenteral

5.9

178.1

569

1228

F10.20

ICD-10 Finland

Alcohol dependence currently independent

15.6

177.9

303

223

N02AX02

ATC

tramadol; systemic, rectal

3.6

175.5

1367

6843

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

150.5

171.1

180

JN3AD

NOMESCO Finland

Abdominal CT examination

6.5

164.6

473

882

P15

ICPC

Chronic alcohol abuse

10.9

163.0

329

348

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

16.1

162.7

273

192

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

55.5

162.1

193

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

6.5

161.3

463

860

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

6.2

157.5

471

921

5770D

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA NONHAEMORHAGICA]

106.8

154.5

168

215

Kela drug reimbursment

Diabetes, non-insulin-treated

3.6

150.6

944

3828

N06AX11

ATC

mirtazapine; oral

3.5

150.3

1011

4328

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.5

149.4

944

3844

N05CF01

ATC

zopiclone; oral

3.4

149.0

1003

4288

N05AH04

ATC

quetiapine; oral

4.2

140.8

633

1910

F10.24

ICD-10 Finland

Alcohol depence active use

17.3

140.4

228

146

T36

ICD-10 Finland

Poisoning by systemic antibiotics

8.7

134.5

309

406

N05BA01

ATC

diazepam; systemic, rectal

4.4

129.5

550

1556

K86.0

ICD-10 Finland

Alcohol-induced chronic pancreatitis

+∞

125.2

119

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

118.7

124.5

134

T90

ICPC

Diabetes non-insulin dependent

3.3

124.5

831

3412

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

3.3

122.4

810

3297

F10.09

ICD-10 Finland

Alcohol intoxication UNS

12.0

120.6

229

210

UJK02

NOMESCO Finland

ERCP

13.9

117.8

209

165

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

9.3

113.0

247

295

R56.8

ICD-10 Finland

Other and unspecified convulsions

6.6

111.6

309

530

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

11.9

111.2

212

195

N05CD07

ATC

temazepam; oral

4.3

110.0

467

1299

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

13.8

109.2

194

153

N05BA02

ATC

chlordiazepoxide; systemic

9.7

108.4

231

263

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

16.1

108.2

180

121

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.3

107.4

447

1217

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

14.1

107.3

189

146

A02BC02

ATC

pantoprazole; systemic

2.8

106.1

1612

10794

N06AB04

ATC

citalopram; systemic

3.3

103.3

656

2531

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

37.8

103.0

132

TPH04

NOMESCO Finland

Cathetrisation of vein

3.1

103.0

705

2870

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

14.8

98.8

170

124

N05BA04

ATC

oxazepam; oral

3.0

96.2

694

2903

K92.0

ICD-10 Finland

Haematemesis

10.6

95.3

192

196

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

93.1

1172

6802

K70.1

ICD-10 Finland

Alcoholic hepatitis

24.3

91.3

131

K85.8

ICD-10 Finland

Other acute pancreatitis

26.8

91.1

127

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

7.2

87.5

224

340

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.1

87.0

579

2268

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

14.6

86.3

149

109

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

7.6

85.7

211

302

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

14.5

85.5

148

109

XF400

NOMESCO Finland

ECG with 12 standard connections

3.1

84.8

559

2168

A02BC01

ATC

omeprazole; systemic

2.7

84.0

755

3568

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

6.0

83.6

246

450

A10BA02

ATC

metformin; oral

2.6

83.5

838

4216

K29.2

ICD-10 Finland

Alcoholic gastritis

52.3

83.3

100

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

15.7

83.2

139

5770F

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA RECIDIVANS]

220.8

82.9

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

130.8

82.6

P16

ICPC

Acute alcohol abuse

10.8

80.1

159

157

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.2

77.9

470

1697

T89

ICPC

Diabetes insulin dependent

6.1

77.6

224

399

Z72.1

ICD-10 Finland

Alcohol use

12.7

77.5

142

119

V03AA01

ATC

8.5

77.3

176

222

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

11.3

77.2

150

142

K86.8

ICD-10 Finland

Other specified diseases of pancreas

50.4

76.2

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.5

76.2

788

3980

R10.0

ICD-10 Finland

Acute abdomen

7.5

74.4

184

264

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

14.4

74.0

128

N05AB01

ATC

dixyrazine; systemic

12.0

73.4

138

122

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

24.7

73.0

104

AA1AD

NOMESCO Finland

CT of head and brain

2.6

70.7

665

3163

N06AX16

ATC

venlafaxine; oral

3.2

69.5

419

1502

ZXD05

NOMESCO Finland

Urgent procedure

2.4

69.0

817

4375

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

109.3

68.3

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

4.1

67.8

288

776

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.6

67.4

638

3031

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

13.6

67.3

119

SPAT1262

SPAT

Handing over of treatment supplies

2.7

66.8

569

2542

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

8.6

64.9

146

180

N05AA02

ATC

levomepromazine; systemic

5.4

64.5

207

417

E13

ICD-10 Finland

Other specified diabetes mellitus

75.6

64.5

A06AD11

ATC

lactulose; oral

3.0

62.2

402

1503

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.4

61.8

338

1118

J01MA12

ATC

levofloxacin; systemic

2.6

61.6

554

2536

N06AB03

ATC

fluoxetine; oral

3.2

61.1

369

1314

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

16.7

61.0

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.7

60.7

491

2112

D64.9

ICD-10 Finland

Anaemia, unspecified

3.5

59.6

309

982

A02BA02

ATC

ranitidine; systemic

2.6

58.3

514

2320

C07AA05

ATC

propranolol; systemic

2.6

57.9

487

2138

E13.7

ICD-10 Finland

Other specified diabetes mellitus, with multiple complications

125.3

57.1

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

4.8

56.7

200

446

JLB35

NOMESCO Finland

Transduodenal endoscopic extraction of foreign body from pancreatic duct

194.8

55.2

A02BC03

ATC

lansoprazole; oral

2.2

55.1

732

4042

A02BC05

ATC

esomeprazole; systemic

2.1

55.1

964

5998

TKC20

NOMESCO Finland

Catheterisation of bladder

3.6

55.0

271

824

K70.0

ICD-10 Finland

Alcoholic fatty liver

16.9

54.6

K83.1

ICD-10 Finland

Obstruction of bile duct

13.0

52.9

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.0

51.1

172

364

C03CA01

ATC

furosemide; systemic

2.2

50.6

623

3295

N06AB10

ATC

escitalopram; oral

2.5

50.6

483

2254

N02BE01

ATC

paracetamol; systemic, rectal

2.4

50.6

1886

15704

N03AX16

ATC

pregabalin; oral

2.3

50.2

600

3130

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.0

49.9

217

591

S06.0

ICD-10 Finland

Concussion

3.2

49.9

296

1032

A10AE05

ATC

insulin detemir; parenteral

3.9

49.3

218

603

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

5.6

48.1

147

278

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

21.5

48.1

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

9.3

48.0

102

114

D02

ICPC

Abdominal pain epigastric

4.4

48.0

183

441

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.1

46.9

672

3780

EBA00

NOMESCO Finland

Extraction of tooth

2.0

46.4

806

4905

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.9

46.2

310

1171

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.3

46.1

257

855

N02AA05

ATC

oxycodone; systemic

2.6

45.6

392

1718

SPAT1265

SPAT

Breathalyser

9.6

45.5

103

N07BA03

ATC

varenicline; oral

3.7

45.0

212

618

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

44.5

315

1227

N06AB06

ATC

sertraline; oral

3.0

44.5

286

1050

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

3.0

44.4

281

1021

P01AB01

ATC

metronidazole; oral, rectal

2.0

44.0

828

5165

5771D

ICD-9 Finland

Diseases of pancreas, Chronic pancreatitis[PANCREATITIS CHRONICA ALCOHOLICA NUD]

+∞

43.9

E87.6

ICD-10 Finland

Hypokalaemia

5.7

43.3

130

241

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

8.5

43.0

117

5771C

ICD-9 Finland

Diseases of pancreas, Chronic pancreatitis[PANCREATITIS CHRONICA ALCOHOLICA RECIDIVANS]

+∞

42.8

N05BA12

ATC

alprazolam; oral

2.8

42.2

292

1122

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

11.3

42.0

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

19.3

41.9

N05BE01

ATC

buspirone; oral

5.1

41.0

136

283

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

6.4

40.9

111

181

UJD02

NOMESCO Finland

Gastroscopy

4.2

40.7

163

411

S01.0

ICD-10 Finland

Open wound of scalp

2.9

40.7

264

972

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

6.5

40.5

108

172

Z2446

NOMESCO Finland

Social worker

3.4

40.1

212

676

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

9.3

39.8

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

9.2

39.1

S22.3

ICD-10 Finland

Fracture of rib

3.1

39.0

231

798

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

11.6

38.8

N03AX12

ATC

gabapentin; oral

2.4

38.7

388

1827

X59

ICD-10 Finland

Exposure to unspecified factor

2.2

38.7

488

2560

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

5.4

38.4

119

229

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.6

37.9

298

1233

R11

ICD-10 Finland

Nausea and vomiting

3.3

37.2

197

628

JLC50

NOMESCO Finland

Atypical pancreatectomy

373.3

37.1

N06AX03

ATC

mianserin; oral

3.9

37.0

160

432

N05CF02

ATC

zolpidem; oral

2.2

37.0

423

2118

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

8.7

36.9

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

36.8

1269

9530

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.9

36.8

125

267

K70.4

ICD-10 Finland

Alcoholic hepatic failure

16.3

36.5

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.8

36.4

253

971

WX892

NOMESCO Finland

Monitored bed care

2.8

36.3

249

947

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

36.0

815

5330

E13.4

ICD-10 Finland

Other specified diabetes mellitus, with neurological complications

188.0

35.9

W19

ICD-10 Finland

Unspecified fall

2.7

35.6

265

1058

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

19.0

35.3

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

10.9

35.2

N06AA12

ATC

doxepin; systemic

3.5

35.1

174

527

K92.1

ICD-10 Finland

Melaena

3.5

35.0

173

522

JLB42

NOMESCO Finland

Transduodenal endoscopic dilatation of pancreatic duct

182.8

34.8

JLD12

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst

96.6

34.8

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

34.5

423

2182

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.7

34.4

160

460

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.1

33.8

203

706

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

33.6

647

3979

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.5

33.5

123

285

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

33.4

365

1781

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.6

33.4

264

1090

J01DA01

ATC

[U] cefalexin; systemic

1.7

33.3

1333

10328

K86.2

ICD-10 Finland

Cyst of pancreas

13.5

33.2

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

32.9

1053

7615

Z3231

NOMESCO Finland

Registered nurse

1.9

32.9

637

3921

SPAT1254

SPAT

Administration of medicine

2.3

32.7

332

1565

F51.0

ICD-10 Finland

Nonorganic insomnia

2.5

32.7

279

1203

J01DB01

ATC

cefalexin; oral

1.9

32.7

1794

15319

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.8

32.3

143

394

R53

ICD-10 Finland

Malaise and fatigue

2.1

32.3

401

2072

ZXE00

NOMESCO Finland

One hour or less

1.8

32.2

830

5608

D01

ICPC

Abdominal pain/cramps general

2.7

32.1

232

909

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

7.4

32.1

109

E87.2

ICD-10 Finland

Acidosis

17.6

31.9

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

6.9

31.9

121

A10BH01

ATC

sitagliptin; oral

2.5

31.6

271

1168

WX110

NOMESCO Finland

Local anesthesy

1.7

31.4

1467

11795

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.6

31.3

149

436

A10AE06

ATC

insulin degludec; parenteral

4.3

31.2

120

291

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.9

31.0

202

741

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

18.1

31.0

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.7

30.6

140

397

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

5.5

30.5

176

N06AX21

ATC

duloxetine; oral

2.5

30.4

250

1055

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.1

30.0

178

614

Z3226

NOMESCO Finland

Physiotherapist

2.0

29.9

432

2369

E13.1

ICD-10 Finland

Other specified diabetes mellitus, with ketoacidosis

306.3

29.9

N03AF01

ATC

carbamazepine; oral, rectal

3.4

29.8

153

476

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.9

29.7

100

212

5770A

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA NONHAEMORRHAGICA]

21.9

29.6

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

9.9

29.2

V03AB30

ATC

8.7

29.0

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

7.0

29.0

108

M79.6

ICD-10 Finland

Pain in limb

1.8

28.9

710

4686

K29.7

ICD-10 Finland

Gastritis, unspecified

4.2

28.7

113

280

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

4.5

28.7

104

238

C07AB07

ATC

bisoprolol; oral

1.7

28.7

1001

7323

S18

ICPC

Laceration/cut

1.7

28.6

904

6425

C08CA01

ATC

amlodipine; oral

1.7

28.6

783

5337

N06AA09

ATC

amitriptyline; systemic

2.5

28.6

239

1017

JAH00

NOMESCO Finland

Laparotomy

4.7

28.5

217

E86

ICD-10 Finland

Volume depletion

5.2

28.5

178

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.0

28.3

176

624

R4110

NOMESCO Finland

Physiotherapy

1.8

28.3

605

3815

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

20.4

28.3

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

7.8

28.0

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

27.7

230

972

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

6.1

27.5

128

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

7.6

27.1

57708

ICD-8 Finland

Diseases of pancreas, Pancreatitis acuta alia

38.3

27.1

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

6.8

27.1

104

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

9.4

27.0

W10

ICD-10 Finland

Fall on and from stairs and steps

3.2

26.6

145

471

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.4

26.0

236

1045

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.0

25.9

106

273

N05AD03

ATC

melperone; systemic

6.9

25.9

M54.5

ICD-10 Finland

Low back pain

1.7

25.9

668

4441

E14.1

ICD-10 Finland

Unspecified diabetes mellitus, with ketoacidosis

40.6

25.8

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.7

25.8

188

739

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

9.5

25.7

A41.9

ICD-10 Finland

Sepsis, unspecified

3.6

25.7

119

341

N05AF03

ATC

chlorprothixene; systemic

3.9

25.7

110

295

A10BB12

ATC

glimepiride; oral

2.7

25.7

190

753

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

15.3

25.5

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.3

25.5

259

1214

J01MA02

ATC

ciprofloxacin; systemic

1.6

25.5

850

6077

57709

ICD-8 Finland

Diseases of pancreas, Pancreatitis NUD

16.9

25.3

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.1

25.3

102

259

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

8.6

25.3

EBA30

NOMESCO Finland

Excision of root of tooth

2.8

25.3

170

636

L17

ICPC

Foot/toe symptom/complaint

1.8

25.3

492

2990

K05.31

ICD-10 Finland

Periodontitis pronounced

2.2

25.1

272

1311

K83.0

ICD-10 Finland

Cholangitis

6.6

25.0

101

UJF32

NOMESCO Finland

Coloscopy

1.8

25.0

549

3470

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

24.8

526

3285

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

24.8

258

1222

SPAT1247

SPAT

Outpatient detoxication and monitoring

9.8

24.8

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

4.5

24.7

208

K29.1

ICD-10 Finland

Other acute gastritis

6.7

24.4

E14.8

ICD-10 Finland

Unspecified diabetes mellitus, with unspecified complications

22.2

24.3

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

24.2

818

5845

N06AB05

ATC

paroxetine; oral

2.8

24.2

163

610

S42.2

ICD-10 Finland

Fracture of upper end of humerus

3.8

24.0

106

292

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

10.0

24.0

5770E

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICAHAEMORRHAGICA]

+∞

24.0

Z2221

NOMESCO Finland

Medical doctor

1.7

23.7

564

3644

JLT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of pancreatic duct

126.3

23.6

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

23.5

419

2462

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

23.5

840

6081

309

Kela drug reimbursment

Nalmefene and naltrexone

11.2

23.4

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.6

23.4

183

749

Z72.0

ICD-10 Finland

Tobacco use

3.9

23.3

254

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

15.4

23.3

N05AH03

ATC

olanzapine; systemic

2.7

23.2

165

638

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.3

23.2

122

387

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

23.1

181

739

C03DA01

ATC

spironolactone; oral

2.2

23.1

245

1169

R03BB04

ATC

tiotropium bromide; inhalant

2.2

23.1

242

1149

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.9

23.0

147

531

K85.1

ICD-10 Finland

Biliary acute pancreatitis

11.2

22.9

S82.6

ICD-10 Finland

Fracture of lateral malleolus

2.8

22.8

158

601

A01

ICPC

Pain general/multiple sites

2.7

22.7

165

645

K20

ICD-10 Finland

Oesophagitis

5.7

22.5

116

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.8

22.5

149

552

F34.1

ICD-10 Finland

Dysthymia

3.8

22.4

268

XF600

NOMESCO Finland

Bloodpressure measurement

2.7

22.4

163

638

N03AG01

ATC

valproic acid; systemic, rectal

2.7

22.3

159

616

J01FF01

ATC

clindamycin; systemic

1.7

22.3

599

3996

G72.8

ICD-10 Finland

Other specified myopathies

5.7

22.1

115

N06AX05

ATC

trazodone; oral

4.4

22.0

189

A46

ICD-10 Finland

Erysipelas

1.9

22.0

336

1863

F05.9

ICD-10 Finland

Delirium, unspecified

5.2

22.0

136

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

8.2

21.9

JLD00

NOMESCO Finland

Pancreaticojejunostomy

+∞

21.9

JLB12

NOMESCO Finland

Transduodenal endoscopic incision of pancreatic duct orifice

+∞

21.9

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

21.8

247

1215

XCK10

NOMESCO Finland

Photography of fundus of eye

2.2

21.7

245

1202

JLC10

NOMESCO Finland

Distal pancreatectomy

20.3

21.7

JLD22

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst to jejunum

222.0

21.6

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

3.0

21.6

129

447

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.3

21.4

207

945

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.0

21.4

313

1709

A02BA04

ATC

nizatidine; systemic

2.4

21.3

187

813

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

21.2

387

2288

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

21.0

797

5810

K86

ICD-10 Finland

Other diseases of pancreas

+∞

20.9

SPAT1227

SPAT

Substance abuse rehabilitation

6.9

20.8

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.6

20.8

158

636

JKA20

NOMESCO Finland

Cholecystectomy

4.0

20.8

215

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.8

20.8

250

F41.09

ICD-10 Finland

UNS Panic Syndrome

4.5

20.7

168

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

11.7

20.7

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

15.0

20.7

JN4BD

NOMESCO Finland

Extensive body CT

2.1

20.6

268

1393

WX290

NOMESCO Finland

Other blockade of nerve

1.5

20.6

907

6844

5772A

ICD-9 Finland

Diseases of pancreas, Cyst and pseudocyst of pancreas[CYSTA ET PSEUDOCYSTA PANCREATIS]

111.0

20.6

L03

ICPC

Low back symptom/complaint

1.8

20.4

441

2747

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

8.3

20.4

SPAT1240

SPAT

Therapeutic discussion

2.2

20.3

214

1018

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

8.2

20.2

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

4.9

20.2

141

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

3.4

20.2

298

K08.3

ICD-10 Finland

Retained dental root

2.3

20.0

200

925

P01

ICPC

Feeling anxious/nervous/tense

2.4

20.0

171

732

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

3.0

20.0

117

401

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.8

20.0

233

WX882

NOMESCO Finland

High dependency care

3.8

20.0

228

WX002

NOMESCO Finland

Sedation and analgesia

1.8

19.9

419

2586

A28

ICPC

Limited function/disability NOS

2.0

19.9

267

1409

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

19.9

141

545

E16.19

ICD-10 Finland

Other specified hypoglycaemia

15.4

19.7

T74.1

ICD-10 Finland

Physical abuse

4.7

19.7

145

P76

ICPC

Depressive disorder

2.8

19.7

129

476

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.6

19.6

147

587

E13.2

ICD-10 Finland

Other specified diabetes mellitus, with renal complications

105.9

19.6

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

19.5

567

3842

JAH33

NOMESCO Finland

Opening of laparostomy

40.4

19.5

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.2

19.4

104

335

N06AA06

ATC

trimipramine; systemic

4.0

19.4

204

WX730

NOMESCO Finland

Conventional respirator

4.6

19.3

148

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

7.9

19.3

F10

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol

16.9

19.2

2910A

ICD-9 Finland

Alcoholic psychoses, Alcohol withdrawal delirium

22.7

19.1

5353A

ICD-9 Finland

Gastritis and duodenitis, Alcoholic gastritis

20.2

19.1

D10

ICPC

Vomiting

3.1

18.8

105

348

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

4.0

18.8

190

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

18.7

332

1936

ZX120

NOMESCO Finland

Intravenous

2.1

18.6

216

1069

P18

ICPC

Medication abuse

9.0

18.6

M04AA01

ATC

allopurinol; systemic

1.9

18.6

307

1744

S97

ICPC

Chronic ulcer skin

2.6

18.6

141

567

JMA10

NOMESCO Finland

Transabdominal total splenectomy

14.3

18.6

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

18.5

428

2715

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

18.4

555

3785

P03

ICPC

Feeling depressed

2.4

18.4

161

700

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

18.4

755

5562

E10

ICD-10 Finland

Type 1 diabetes mellitus

4.2

18.3

171

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

18.2

290

1626

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

17.9

351

2112

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

17.9

317

1845

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.9

17.9

113

407

K02.1

ICD-10 Finland

Caries of dentine

1.5

17.9

1149

9324

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.6

17.8

231

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.4

17.7

162

719

Z71.8

ICD-10 Finland

Other specified counselling

1.7

17.7

430

2763

B01AB05

ATC

enoxaparin; parenteral

1.6

17.7

602

4232

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

10.4

17.7

SPAT1301

SPAT

No procedures

1.6

17.6

588

4113

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

6.5

17.5

R06.0

ICD-10 Finland

Dyspnoea

1.7

17.5

463

3046

F10.02

ICD-10 Finland

Alcohol-related acute intoxication with other acute clinical complications

17.1

17.4

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.6

17.4

225

TK800

NOMESCO Finland

Hemodialysis

3.5

17.2

237

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

17.1

439

2859

WX872

NOMESCO Finland

Intensive care

2.4

17.1

152

663

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

17.1

240

1286

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.9

17.0

103

361

R41.0

ICD-10 Finland

Disorientation, unspecified

3.4

17.0

245

GBB00

NOMESCO Finland

Tracheostomy

5.0

16.9

110

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.3

16.9

146

F61.0

ICD-10 Finland

Mixed personality disorders

4.3

16.8

151

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

16.8

568

3977

F32

ICD-10 Finland

Depressive episode

2.9

16.8

104

371

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

3.2

16.7

286

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.3

16.7

160

724

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.0

16.6

172

SPAT1263

SPAT

Sampling

1.5

16.6

784

5926

N05CD08

ATC

midazolam; nasal, systemic

4.3

16.6

144

M10.9

ICD-10 Finland

Gout, unspecified

2.2

16.5

170

799

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

16.4

16.5

-1

NOMESCO Finland

1.5

16.5

632

4559

S10

ICPC

Boil/carbuncle

2.5

16.4

130

533

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

20.2

16.4

K30

ICD-10 Finland

Functional dyspepsia

2.1

16.4

194

971

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.5

16.4

132

P29

ICPC

Psychological sympt/compl other

2.7

16.3

113

431

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

5.5

16.3

D11

ICPC

Diarrhoea

2.1

16.3

199

1005

N06AG02

ATC

moclobemide; oral

2.7

16.3

112

425

Y07

ICD-10 Finland

Other maltreatment

6.5

16.3

N03AX09

ATC

lamotrigine; oral

2.8

16.2

107

395

L28

ICPC

Limited function/disability (L)

1.9

16.0

272

1556

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

15.9

231

1251

ZXD35

NOMESCO Finland

Usual procedure

3.0

15.9

334

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

4.4

15.9

136

N06AX12

ATC

bupropion; oral

2.4

15.9

137

592

R95

ICPC

Chron obstructive pulmonary disease

3.3

15.8

243

D07AA02

ATC

hydrocortisone; topical

1.9

15.8

252

1414

S42.0

ICD-10 Finland

Fracture of clavicle

3.2

15.8

260

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

7.4

15.7

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.7

15.7

112

434

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

9.8

15.7

N03AE01

ATC

clonazepam; systemic

2.4

15.6

135

583

R50.9

ICD-10 Finland

Fever, unspecified

1.8

15.6

282

1648

R18

ICD-10 Finland

Ascites

4.3

15.6

139

A10BK03

ATC

empagliflozin; oral

2.1

15.4

191

973

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

14.8

15.3

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.4

15.3

127

S72.1

ICD-10 Finland

Pertrochanteric fracture

4.8

15.3

109

F32.1

ICD-10 Finland

Moderate depressive episode

2.7

15.3

106

403

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.9

15.3

166

E14

ICD-10 Finland

Unspecified diabetes mellitus

11.3

15.3

C09AA02

ATC

enalapril; systemic

1.6

15.2

403

2641

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

9.8

15.2

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

9.8

15.2

A03DA02

ATC

pitofenone and analgesics; systemic

5.3

15.1

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

10.9

15.0

B03BA03

ATC

hydroxocobalamin; parenteral

2.6

15.0

112

448

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.0

14.9

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.9

14.8

316

E87.5

ICD-10 Finland

Hyperkalaemia

4.3

14.8

127

N05AD01

ATC

haloperidol; systemic

3.1

14.8

282

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.1

14.7

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.4

14.7

213

JAH01

NOMESCO Finland

Laparoscopy

3.0

14.7

302

S20.2

ICD-10 Finland

Contusion of thorax

2.4

14.7

126

542

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

13.3

14.7

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

14.7

163

791

C09AA05

ATC

ramipril; oral

1.5

14.6

514

3614

D06

ICPC

Abdominal pain localized other

2.3

14.5

139

632

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

8.1

14.5

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

2.7

14.5

370

E13.3

ICD-10 Finland

Other specified diabetes mellitus, with ophthalmic complications

36.3

14.4

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

12.6

14.4

R60.0

ICD-10 Finland

Localized oedema

1.9

14.4

209

1133

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.8

14.3

343

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

14.3

259

1515

205

Kela drug reimbursment

Chronic hypertension

1.5

14.3

540

3859

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.2

14.3

246

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.3

14.2

131

585

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.9

14.2

152

B18.2

ICD-10 Finland

Chronic viral hepatitis C

4.6

14.2

105

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

5.6

14.0

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.2

14.0

147

695

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.2

14.0

125

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3000570) Elastase.pancreatic [Mass/mass] in Stool

473

538

10.65

307.65

1.7

1.4

ug/g

162.7

271.2

15.81

253

329

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1462

6254

4.30

276.93

6.8

2.6

u/l

78.0

57.7

8.90

1378

5832

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

720

2301

4.01

195.33

4.9

3.0

umol/l

10.4

9.0

0.57

630

2055

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1807

10380

3.80

193.19

11.9

6.7

umol/l

12.4

12.2

0.23

1737

9908

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

627

1875

4.15

185.81

7.7

2.4

u/l

305.2

39.1

1.27

544

1647

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

812

3048

3.49

169.98

3.2

1.9

1.5

15.39

696

2681

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

604

1930

3.82

160.81

3.1

2.4

g/l

0.2

9.82

559

1805

(3023183) Ammonium ion [Moles/volume] in Plasma

297

543

6.08

157.95

3.4

2.9

umol/l

38.2

36.5

0.29

251

463

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

186

207

9.64

153.69

1.4

1.2

nmol/l

0.9

1.5

8.86

167

188

(3024561) Albumin [Mass/volume] in Serum or Plasma

1492

8447

2.95

146.03

7.9

5.4

g/l

33.0

35.6

43.07

1407

7922

(3023368) Bacteria identified in Blood by Culture

1139

5698

2.86

138.95

6.6

4.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1271

6805

2.80

134.93

5.2

3.4

u/l

47.3

38.0

0.58

1197

6475

(3003458) Phosphate [Moles/volume] in Serum or Plasma

701

2753

3.16

131.75

7.5

7.0

mmol/l

1.0

0.36

671

2594

(3012095) Magnesium [Moles/volume] in Serum or Plasma

803

3471

2.95

126.59

4.7

3.8

mmol/l

0.7

0.8

38.86

770

3284

(3014111) Lactate [Moles/volume] in Serum or Plasma

527

1874

3.31

115.54

12.1

8.0

mmol/l

1.7

1.4

2.54

512

1807

(3014576) Chloride [Moles/volume] in Serum or Plasma

673

2770

2.97

114.46

13.8

7.7

mmol/l

102.8

104.4

10.47

659

2705

(3013826) Glucose [Moles/volume] in Serum or Plasma

1783

12045

2.75

108.84

10.6

5.1

mmol/l

8.0

6.8

45.17

1730

11378

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

238

497

5.19

108.48

1.5

1.7

nmol/l

0.6

0.8

6.31

193

416

(3009508) Creatinine [Moles/volume] in Urine

1201

6784

2.51

106.61

4.2

3.3

mmol/l

6.7

8.5

36.03

1037

5759

(3017315) Amylase [Enzymatic activity/volume] in Urine

108

11.97

105.55

1.8

1.2

u/l

596.7

465.6

0.22

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1503

9468

2.51

104.28

11.9

7.5

mmol/l

1.2

13.68

1288

8029

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1415

8674

2.49

104.19

11.5

6.7

mmol/l

1.2

14.13

1335

7915

(3000991) Gas panel - Venous blood

484

1770

3.16

100.11

14.7

9.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

146

205

7.51

99.27

2.7

1.4

promille

1.9

1.4

1.95

111

159

(3032080) INR in Blood by Coagulation assay

1385

8530

2.43

99.10

10.2

9.1

inr

1.2

1.3

0.79

408

2423

(3012544) pH of Venous blood

513

1996

2.98

94.77

6.0

4.0

—

7.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

494

1907

2.99

92.37

6.0

4.1

kpa

5.8

0.59

480

1851

(3020682) Albumin/Creatinine [Ratio] in Urine

1163

6780

2.36

92.25

5.1

4.1

mg/mmol

15.6

9.3

3.20

815

4530

(3002032) Base excess in Venous blood by calculation

494

1916

2.98

91.52

6.0

4.1

mmol/l

1.5

2.0

1.49

405

1533

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

876

4526

2.45

91.21

2.6

2.1

mg/l

3.0

2.9

0.11

762

3875

(3012516) Albumin [Mass/volume] in Urine

1117

6455

2.34

89.74

4.2

3.3

mg/l

321.9

286.9

0.11

799

4345

(3003396) Base excess in Arterial blood by calculation

576

2496

2.71

86.05

13.8

8.2

mmol/l

0.5

1.0

1.21

469

1964

(3033658) Prothrombin time (PT) actual/Normal

962

5293

2.34

85.73

8.5

4.3

84.9

88.2

3.93

930

5192

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

573

2501

2.68

84.19

13.9

8.2

kpa

5.0

5.1

1.53

549

2407

(3027801) Oxygen [Partial pressure] in Arterial blood

573

2502

2.68

84.12

13.9

8.1

kpa

11.5

12.2

3.06

551

2411

(3020779) Urea [Moles/volume] in Serum or Plasma

496

2026

2.81

82.81

8.7

8.8

mmol/l

9.2

9.8

1.24

479

1943

(3016502) Oxygen saturation in Arterial blood

530

2291

2.67

78.89

14.6

8.5

95.4

95.7

0.46

515

2215

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2017

15478

2.70

78.67

14.3

7.8

u/l

94.6

77.6

18.65

1946

14672

(3018418) pH of Serum or Plasma

971

5531

2.25

77.95

5.6

4.5

7.4

0.11

210

1121

(3028707) Methadone [Presence] in Urine by Screen method

147

274

5.64

75.61

3.0

3.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

171

366

4.95

75.27

1.1

iu/ml

28.7

110.8

1.42

(3002173) Hemoglobin [Mass/volume] in Arterial blood

494

2113

2.67

74.73

15.0

9.0

g/l

119.1

124.3

5.56

481

2041

(3024354) Oxygen [Partial pressure] in Venous blood

400

1548

2.89

73.24

4.6

3.3

kpa

4.7

0.05

383

1497

(3019309) Folate [Moles/volume] in Red Blood Cells

671

3343

2.39

73.13

2.0

1.7

nmol/l

1224.7

1163.4

0.84

533

2575

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

299

997

3.28

70.86

6.0

4.3

mmol/l

23.7

24.2

1.28

269

900

(3042936) Bacteria identified in Isolate by Culture

617

3024

2.39

69.31

2.9

2.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1195

7657

2.09

68.38

2.4

1.9

pmol/l

89.7

94.0

2.08

704

4260

(44816559) Phosphatidylethanol [Mass/volume] in Blood

180

436

4.38

67.90

2.1

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

631

3148

2.35

67.88

2.1

1.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

9.36

66.25

2.9

2.8

umol/l

99.3

129.2

0.47

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

251

782

3.46

66.17

2.4

2.5

ug/l

569.8

580.1

0.02

241

750

(3044640) Blood type and Crossmatch panel - Blood

1010

6154

2.09

65.35

3.9

2.6

—

(3011288) Drugs identified in Urine by Screen method

164

382

4.53

65.00

3.5

3.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

147

333

4.63

60.27

1.5

1.7

g/l

0.8

0.9

0.07

258

(3003181) Sodium [Moles/volume] in Urine

140

310

4.73

59.02

1.5

1.3

mmol/l

52.5

65.4

2.52

105

249

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1000

6263

2.01

58.22

2.9

2.3

u/l

271.4

271.9

0.00

940

5905

(3026782) Osmolality of Urine

704

3894

2.13

57.41

3.4

2.8

mosm/kgh2o

477.8

578.4

25.35

627

3338

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

815

4790

2.05

56.28

3.6

2.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

568

2908

2.24

56.15

3.0

2.7

g/l

2.2

2.3

2.50

533

2746

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

298

1140

2.84

54.96

17.2

11.0

mmol/l

23.6

24.3

1.97

283

1082

(1001926) Buprenorphine [Presence] in Urine by Screen method

173

477

3.83

54.56

3.0

2.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1545

11379

1.96

54.50

9.4

9.7

e9/l

4.9

4.2

21.25

1379

9974

(3021960) Folate [Moles/volume] in Serum or Plasma

734

4206

2.06

53.92

1.8

1.5

nmol/l

20.1

19.8

0.17

660

3637

(3022948) Iron [Moles/volume] in Serum or Plasma

587

3099

2.17

53.44

3.1

2.7

umol/l

12.1

13.5

3.69

552

2919

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

227

762

3.18

52.72

3.1

3.9

u/ml

292.4

3216.8

1.17

199

663

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

535

2737

2.22

52.61

3.2

2.8

23.5

23.9

0.19

456

2384

(3027923) C peptide [Moles/volume] in Serum or Plasma

123

6.86

52.31

1.4

nmol/l

0.8

1.2

2.51

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

133

6.58

52.11

1.3

1.2

mmol/l

12.2

12.4

0.07

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

458

2206

2.32

52.00

2.0

1.8

—

(36304419) Bacteria [Presence] in Urine

876

5413

1.96

51.51

4.1

3.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1596

12008

1.94

51.32

5.4

3.9

e6/l

895.7

849.0

0.03

187

(3000850) Epithelial cells [#/volume] in Urine

725

4203

2.03

51.12

3.5

2.6

e6/l

5.9

3.8

2.75

671

3701

(3002582) Erythrocytes [#/volume] in Urine

955

6099

1.93

50.71

4.3

3.3

e6/l

80.6

89.4

0.08

789

4759

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

328

1374

2.60

50.44

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

452

2194

2.30

50.25

1.9

1.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

303

1231

2.67

49.53

17.6

11.2

—

(3030467) Casts [#/volume] in Urine by Automated count

885

5555

1.93

49.15

4.2

3.2

e6/l

0.6

0.4

1.25

725

4222

(3018095) Leukocytes [#/volume] in Urine

1036

6885

1.87

47.93

4.8

3.7

e6/l

48.7

92.8

2.07

818

5085

(3018677) aPTT in Platelet poor plasma by Coagulation assay

602

3333

2.07

47.69

2.0

2.2

30.8

30.0

2.29

580

3246

(3007853) Bacteria identified in Skin by Aerobe culture

466

2353

2.21

46.80

2.1

1.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

450

2243

2.23

46.65

2.5

2.6

2.0

1.8

2.83

401

2009

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1796

14273

1.96

46.42

7.3

3.2

u/l

112.6

55.9

23.50

1712

13436

(3016879) Cocaine [Presence] in Urine

181

577

3.31

45.66

3.0

2.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

926

6043

1.85

44.53

3.3

3.6

mmol/l

2.3

5.42

820

5342

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1280

9254

1.80

43.57

5.7

4.1

—

(3026008) Bacteria identified in Urine by Culture

725

4404

1.92

43.39

3.5

2.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

675

4007

1.94

43.27

5.1

3.8

ng/l

194.3

792.6

1.74

550

3224

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

276

1149

2.58

42.69

1.7

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

183

613

3.14

42.48

3.1

2.3

—

(42870588) Differential panel, method unspecified - Blood

1006

6827

1.80

41.88

5.4

6.2

—

(3019060) Gas panel - Arterial blood

324

1466

2.39

41.86

8.6

5.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

399

1978

2.21

41.55

3.3

4.6

ug/l

29.1

22.9

0.13

361

1648

(3028300) Cannabinoids [Presence] in Urine

183

621

3.10

41.54

3.2

2.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1065

7397

1.78

40.61

3.5

2.8

ug/l

186.0

176.2

0.41

983

6865

(3017143) Hepatitis C virus Ab [Presence] in Serum

426

2194

2.14

40.18

1.7

—

(3006315) Basophils [#/volume] in Blood

1338

9961

1.75

39.69

6.0

6.2

e9/l

0.0

5.06

1153

8668

(3027008) Opiates [Presence] in Urine

179

618

3.05

39.41

3.0

2.3

—

(3019198) Lymphocytes [#/volume] in Blood

1359

10188

1.75

39.08

6.1

6.2

e9/l

1.9

1.05

1181

9022

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

437

2307

2.09

38.49

1.7

1.6

—

(3001604) Monocytes [#/volume] in Blood

1327

9923

1.73

38.12

6.0

6.2

e9/l

0.7

0.6

10.80

1142

8624

(3027944) Amphetamines [Presence] in Urine

175

609

3.02

37.98

3.1

2.2

—

(40758558) Short blood count panel - Blood

773

4959

1.82

37.97

7.0

7.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

287

1283

2.40

37.93

4.5

3.6

g/l

126.3

131.2

2.62

277

1254

(3022096) Basophils/100 leukocytes in Blood

1233

9047

1.73

37.82

5.8

6.5

0.7

0.02

1164

8487

(3019069) Monocytes/100 leukocytes in Blood

1261

9355

1.71

36.76

5.9

6.7

8.9

0.03

1194

8791

(3007566) Smooth muscle Ab [Titer] in Serum

168

586

3.00

36.30

1.2

1.3

titre

100.0

92.3

0.09

(3006504) Eosinophils/100 leukocytes in Blood

1253

9303

1.71

36.22

5.8

6.4

2.7

2.9

2.73

1183

8703

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

229

941

2.58

36.21

1.8

g/l

1.6

1.5

0.30

199

810

(3013115) Eosinophils [#/volume] in Blood

1355

10302

1.70

35.62

6.4

e9/l

0.2

1.13

1177

9093

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1013

7129

1.72

35.43

2.6

2.2

nmol/l

67.6

75.5

12.19

898

6436

(3023520) Reticulocytes [#/volume] in Blood

338

1666

2.19

35.35

2.6

2.8

e9/l

70.8

70.1

0.13

250

1263

(3018010) Neutrophils/100 leukocytes in Blood

1261

9448

1.69

34.64

5.7

6.3

59.4

57.4

7.81

1193

8880

(3002030) Lymphocytes/100 leukocytes in Blood

1276

9593

1.69

34.58

5.9

6.5

25.0

27.4

12.40

1202

8967

(3022217) INR in Platelet poor plasma by Coagulation assay

471

2662

1.95

33.88

17.4

23.2

inr

1.1

1.3

3.59

386

(3008152) Bicarbonate [Moles/volume] in Arterial blood

294

1396

2.26

33.62

12.7

7.4

mmol/l

24.1

24.5

0.78

278

1308

(1616796) Gas panel - Central venous blood

145

487

3.10

33.43

4.4

4.0

—

(40768797) Stomach Pathology biopsy report

471

2695

1.92

32.54

1.5

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

567

3446

1.84

32.44

3.3

2.8

e6/l

1.1

0.9

0.89

342

2019

(3042517) Benzodiazepines panel - Urine

17.05

32.41

2.4

1.7

—

(4198724)

6.04

30.78

2.2

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

134

453

3.07

30.54

2.8

3.7

u/ml

1046.2

290.8

0.47

121

425

(3052851) Hemolysis interference index of Serum or Plasma

156

576

2.82

30.35

5.2

3.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

535

3253

1.82

30.32

2.9

3.3

mmol/l

2.5

2.4

1.67

461

2866

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1071

7878

1.64

30.13

5.5

3.5

ng/l

71.8

56.9

0.14

861

5605

(3036481) Cortisol [Moles/volume] in Serum or Plasma

331

1733

2.05

29.28

2.2

2.4

nmol/l

379.2

362.6

0.74

307

1610

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

246

1148

2.27

29.18

1.8

1.6

—

(1761868) Lipid panel - Serum or Plasma

531

8061

0.56

29.11

3.4

2.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

480

2855

1.85

29.09

1.9

1.7

—

(3020891) Body temperature

202

868

2.45

28.92

8.5

5.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

528

3240

1.80

28.86

3.4

3.0

e6/l

1.6

1.2

0.51

304

1820

(3024928) Oxygen saturation in Venous blood

136

479

2.95

28.84

3.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

611

3921

1.74

28.59

1.8

1.7

pmol/l

468.0

33695740.0

3.68

512

3315

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

217

974

2.35

28.17

4.6

2.8

0.7

0.27

209

933

(3012501) Base excess in Blood by calculation

136

487

2.90

27.99

6.1

5.0

mmol/l

2.5

2.4

0.21

100

321

(3028192) IgG subclass 2 [Mass/volume] in Serum

205

4.00

27.90

1.2

g/l

3.1

3.0

0.17

143

(3024139) IgG subclass 3 [Mass/volume] in Serum

205

4.00

27.90

1.2

g/l

0.4

0.25

142

(3027135) IgG subclass 1 [Mass/volume] in Serum

205

4.00

27.90

1.2

g/l

6.1

6.8

0.92

142

(4062490)

206

3.98

27.72

1.2

1.3

—

(3010421) pH of Blood

149

565

2.74

27.55

6.2

5.0

7.4

0.07

134

478

(3027273) Bicarbonate [Moles/volume] in Venous blood

216

979

2.32

27.41

5.6

3.8

mmol/l

24.9

25.2

0.58

208

948

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

409

2394

1.85

25.82

2.7

4.5

u/l

235.9

245.1

0.35

387

2280

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

253

1264

2.12

25.21

5.5

4.6

ng/l

117.3

98.6

1.26

214

1133

(3005719) IgG [Mass/volume] in Serum or Plasma

300

1603

1.99

24.88

1.9

2.7

g/l

11.2

10.7

0.99

246

1485

(3051651) Icteric interference index of Serum or Plasma

120

4.75

24.56

5.4

3.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

195

901

2.26

23.59

6.0

4.2

50.3

50.9

0.11

189

889

(3037467) Urinalysis macro (dipstick) panel - Urine

1577

13141

1.56

23.39

5.1

3.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

366

2140

1.83

23.00

5.9

3.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

266

1401

2.01

22.91

4.3

3.5

kpa

5.1

0.19

244

1306

(3028626) Oxygen [Partial pressure] in Capillary blood

123

469

2.71

22.50

3.4

2.8

kpa

7.9

8.0

0.16

116

428

(3007164) IgA [Mass/volume] in Serum or Plasma

531

3478

1.67

22.30

1.4

1.5

g/l

3.7

2.7

11.53

315

2232

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

144

596

2.50

22.30

1.3

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

179

3.82

22.09

5.6

3.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

5.79

21.96

1.5

2.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

252

1322

2.01

21.92

4.2

3.5

mmol/l

1.5

1.7

0.18

185

993

(3009343) pH of Capillary blood

260

1380

1.99

21.88

4.3

3.5

7.4

0.68

178

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

139

574

2.51

21.63

2.3

ug/min

243.3

119.0

1.06

364

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

191

907

2.20

21.59

2.5

2.1

ug/l

2.8

1.8

0.46

179

833

(3021589) Normoblasts [#/volume] in Blood

1126

8837

1.51

21.25

14.2

9.9

e9/l

0.0

0.15

928

7309

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

133

543

2.53

21.20

1.2

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

188

3.64

20.59

1.6

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

120

473

2.62

20.56

3.5

2.5

15.6

16.5

1.52

248

(3020630) Protein [Mass/volume] in Serum or Plasma

291

1641

1.88

20.39

1.9

2.8

g/l

65.7

66.7

1.23

265

1521

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

181

884

2.13

19.04

10.3

5.6

2.2

1.7

3.78

171

831

(3043409) Potassium [Moles/volume] in Arterial blood

148

667

2.30

18.97

7.3

4.5

mmol/l

3.9

0.82

139

626

(3047181) Lactate [Moles/volume] in Blood

151

689

2.27

18.80

11.4

6.6

mmol/l

1.7

1.4

2.24

128

611

(3016038) Potassium [Moles/volume] in Urine

109

4.38

18.75

1.3

1.2

mmol/l

25.2

35.9

2.33

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

543

3721

1.59

18.59

1.4

1.2

u/ml

2.6

2.0

0.26

144

1013

(3033799) Differential panel - Peritoneal fluid

4.94

18.51

1.9

2.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

145

665

2.25

17.83

2.4

1.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

320

1935

1.75

17.70

3.2

2.3

ug/l

4.7

9.6

8.51

289

1764

(3004588) Protein electrophoresis panel - Serum or Plasma

244

1363

1.88

17.53

1.8

2.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

175

873

2.08

17.41

10.2

5.6

0.9

0.72

166

823

(3023487) Leukocytes [#/volume] in Peritoneal fluid

4.48

17.30

2.3

2.4

e6/l

541.0

824.4

0.43

(3021901) Oxygen saturation in Capillary blood

102

405

2.58

17.25

3.6

2.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

158

762

2.15

17.16

2.8

3.0

u/ml

0.3

0.58

419

(3008295) Osmolality of Serum or Plasma

208

3.23

16.99

1.5

1.3

mosm/kgh2o

274.3

283.6

2.02

164

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

379

2.62

16.95

1.3

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

6.14

16.39

2.5

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2130

0.41

16.22

2.0

1.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

598

4313

1.51

15.93

4.1

3.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

13.71

15.92

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

112

3.98

15.58

1.2

1.3

nmol/l

156.4

146.2

0.48

112

(3015235) Bicarbonate [Moles/volume] in Capillary blood

124

574

2.22

14.94

3.9

3.0

mmol/l

24.2

24.9

0.86

108

498

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

353

2.55

14.61

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1650

14479

1.42

14.55

4.3

3.9

mm/h

16.5

11.1

25.10

1521

13458

(21494755) Public health laboratory ask at order entry panel

111

2271

0.46

14.35

1.3

1.4

—

(3044007) Cell count panel - Peritoneal fluid

4.57

14.00

2.1

2.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

256

1550

1.73

13.99

6.0

4.5

mmol/l

1.2

1.49

241

1374

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

588

4326

1.47

13.93

1.7

1.8

mg/l

1.5

1.2

0.85

460

3343

(3016650) Hepatitis A virus Ab [Presence] in Serum

343

2.50

13.46

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

380

2577

1.56

13.20

1.3

titre

354.5

456.0

0.58

493

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

129

639

2.07

13.10

2.1

2.6

g/l

3.8

3.6

0.71

121

611

(3028026) IgM [Mass/volume] in Serum or Plasma

213

1256

1.76

12.76

1.5

1.9

g/l

1.3

1.4

0.59

198

1169

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

717

1.99

12.64

1.8

2.4

g/l

3.2

3.0

0.83

108

578

(3018572) Chloride [Moles/volume] in Blood

107

504

2.17

12.39

13.9

7.4

mmol/l

102.9

105.4

3.26

456

(3039000) Anion gap in Blood

107

504

2.17

12.39

13.9

7.4

mmol/l

12.4

11.6

1.18

456

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

304

2.51

12.24

6.9

6.7

mg/l

11.8

11.3

0.55

283

(3022313) Gas panel - Capillary blood

178

1008

1.83

12.21

4.5

3.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

136

706

1.98

12.15

1.9

2.4

g/l

10.5

10.6

0.12

110

612

(3006184) Hemoglobin [Mass/volume] in Capillary blood

457

2.22

12.05

2.7

2.2

g/l

124.4

132.2

2.21

328

(3021879) Hepatitis B virus core Ab [Presence] in Serum

235

1447

1.69

12.04

1.4

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

143

758

1.94

12.03

1.8

2.4

g/l

3.9

0.10

107

569

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

143

758

1.94

12.03

1.8

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

143

758

1.94

12.03

1.8

2.4

g/l

7.4

7.2

0.39

108

592

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

120

598

2.06

12.01

2.0

2.4

g/l

36.1

37.8

1.69

101

531

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

145

3.21

11.92

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

145

3.21

11.92

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

151

3.15

11.81

1.1

—

(3000494) Fungus identified in Specimen by Culture

365

2518

1.53

11.65

1.6

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

393

2.28

11.60

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

393

2.28

11.60

1.4

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.92

11.55

2.4

2.2

e6/l

877.3

2851.9

1.33

(3026692) Albumin [Mass/volume] in Peritoneal fluid

4.30

11.48

1.9

1.5

g/l

9.4

12.1

0.75

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

111

547

2.08

11.46

2.0

2.4

g/l

0.0

0.00

510

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

116

584

2.03

11.31

2.0

2.4

g/l

0.0

0.17

101

547

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

109

542

2.06

11.00

2.0

2.4

g/l

0.0

0.00

509

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

126

662

1.95

10.90

2.0

2.6

g/l

0.2

1.3

5.01

105

586

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

119

614

1.99

10.84

2.4

3.8

ratio

1.2

2.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

121

628

1.97

10.84

2.4

3.8

mg/l

115.6

53.3

0.57

494

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

438

2.17

10.81

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

121

629

1.97

10.79

2.3

3.8

mg/l

46.2

52.5

0.24

497

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

348

2.31

10.78

1.1

g/l

1.6

1.5

0.55

317

(3035350) Ketones [Presence] in Urine by Test strip

1103

9322

1.33

10.75

4.4

3.2

estimate

0.0

0.50

236

1737

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

120

3.29

10.54

2.9

2.1

ug/min

89.3

348.2

0.75

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

132

3.14

10.30

1.5

1.6

—

(3019977) pH of Arterial blood

127

3.18

10.28

3.6

2.7

7.4

0.24

(3010813) Leukocytes [#/volume] in Blood

2181

22719

0.64

10.08

43.4

20.7

e9/l

7.7

6.7

67.88

2138

22130

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.54

10.04

1.1

6.1

mg/l

57.4

63.8

0.28

(3000963) Hemoglobin [Mass/volume] in Blood

2181

22716

0.64

10.00

43.8

20.8

g/l

130.2

140.2

125.98

2159

22409

(3026361) Erythrocytes [#/volume] in Blood

2181

22713

0.64

9.93

43.4

20.7

e12/l

4.3

4.6

129.53

2134

22125

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

715

5720

1.35

9.90

2.9

3.0

ng/l

1897.7

1368.6

1.59

626

4888

(3024731) MCV [Entitic volume]

2181

22711

0.64

9.88

43.3

20.6

92.2

91.1

20.08

2162

22410

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1360

0.43

9.86

1.5

—

(3035941) MCH [Entitic mass]

2181

22709

0.65

9.83

43.2

20.6

30.8

30.5

9.40

2162

22408

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

118

631

1.91

9.72

4.0

2.9

mg/l

1.8

1.6

2.44

103

585

(3007461) Platelets [#/volume] in Blood

2181

22699

0.65

9.59

43.4

20.7

e9/l

246.2

240.9

2.50

2144

22169

(3021601) Nitrite [Presence] in Urine by Test strip

1090

9305

1.31

9.47

5.5

4.4

estimate

0.0

0.50

250

1807

(3040151) Glucose [Moles/volume] in Capillary blood

236

2.49

9.46

124.6

6.2

mmol/l

8.3

7.3

1.52

197

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

134

756

1.82

9.34

2.6

2.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

478

2.03

9.33

2.3

4.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

104

3.30

9.30

2.9

3.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1547

13881

1.31

9.11

3.8

3.4

pmol/l

14.6

14.8

1.19

1394

12656

(3029937) Albumin [Presence] in Urine by Test strip

641

5097

1.35

9.10

5.1

3.6

estimate

0.0

0.06

222

1687

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

463

2.03

9.04

1.4

1.6

—

(3025941) Bacteria identified in Stool by Culture

167

1015

1.69

9.00

1.4

1.2

—

(3019150) Specific gravity of Urine by Refractometry

527

4090

1.37

8.71

4.7

3.5

kg/l

1.0

0.79

554

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1953

20679

0.73

8.66

5.1

4.5

mmol/l

4.2

4.6

44.56

1807

19391

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

145

860

1.73

8.55

4.8

3.8

mmol/l

24.5

24.8

0.48

138

805

(3026493) Urate [Moles/volume] in Serum or Plasma

726

5924

1.32

8.54

2.8

umol/l

4248.4

4110.7

0.03

634

5235

(3009261) Glucose [Presence] in Urine by Test strip

1092

9411

1.29

8.52

4.4

3.3

estimate

0.0

1.49

219

1666

(40768446) Kidney Pathology biopsy report

105

3.17

8.50

1.8

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1943

20570

0.73

8.36

5.0

4.5

mmol/l

1.3

1.4

11.79

1775

19195

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.99

8.33

1.6

1.4

g/l

16.3

25.0

1.54

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

120

689

1.78

7.93

1.7

2.2

80.1

89.4

3.21

115

654

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

108

606

1.82

7.71

1.8

2.5

235.9

195.4

3.22

100

576

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

193

2.46

7.58

1.1

1.2

u/l

52.5

54.3

0.13

137

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

124

729

1.74

7.57

2.1

1.7

—

(3017181) Myelocytes/100 leukocytes in Blood

250

1742

1.48

7.51

3.1

4.5

0.9

0.02

547

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2123

20137

1.40

7.38

32.0

14.3

mg/l

35.7

25.5

24.00

1951

15976

(3036489) Thrombin time

131

788

1.70

7.37

1.7

2.1

24.0

22.0

0.90

120

700

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

499

1.88

7.33

1.5

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

221

2.34

7.33

3.2

4.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

238

1654

1.49

7.25

3.2

2.8

ng/l

240.7

184.1

0.94

213

1504

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

131

792

1.69

7.24

2.3

1.9

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

282

2.16

7.12

1.1

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

109

2.87

6.79

2.1

2.2

umol/l

30.8

36.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

842

9751

0.79

6.77

3.9

21.8

21.5

0.22

349

4420

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

506

1.83

6.73

1.2

—

(3019225) pH of Specimen

258

1856

1.44

6.57

6.1

4.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

117

2.76

6.54

1.3

1.4

—

(3012441) Differential panel - Pleural fluid

221

2.24

6.46

1.7

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

221

2.24

6.46

1.7

1.5

e6/l

34331.9

70666.8

0.79

134

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

190

2.34

6.41

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

662

5508

1.28

6.40

1.9

1.7

mmol/l

1.7

1.5

2.37

578

4605

(3023199) Leukocytes [#/volume] in Pleural fluid

248

2.16

6.39

1.6

1.5

e6/l

20510.3

1656.8

0.48

181

(3014765) Yersinia sp identified in Stool by Organism specific culture

508

1.80

6.36

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

923

0.46

6.36

1.3

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

202

1397

1.49

6.32

1.6

1.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.26

6.27

3.3

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.26

6.27

3.3

2.5

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

18.06

6.26

1.3

1.0

mmol/l

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

218

2.23

6.24

1.1

—

(36660697) Celiac disease serology panel - Serum

193

1326

1.49

6.23

1.2

—

(3045788) Cell count panel - Pleural fluid

193

2.30

6.20

1.6

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

513

1.78

6.17

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

224

1589

1.45

6.16

3.0

4.3

0.5

0.6

0.41

397

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1871

17548

1.28

6.11

4.9

4.0

mu/l

2.0

2.2

0.54

1714

16054

(4010399)

204

1424

1.47

6.09

1.5

1.4

—

(3004775) Volume in Urine collected for unspecified duration

182

2.33

6.09

2.1

2.2

796.6

641.5

1.42

117

(3021440) Promyelocytes/100 leukocytes in Blood

231

1652

1.44

6.08

3.2

4.5

0.1

0.66

507

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

3.00

5.95

1.1

u/l

60.3

28.0

0.62

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

3.00

5.95

1.1

u/l

118.0

93.6

0.28

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

244

1770

1.42

5.94

3.3

2.6

ml/min/173m2

66.7

68.2

0.16

100

653

(3045716) Anion gap in Serum or Plasma

112

2.70

5.92

3.7

2.8

mmol/l

9.3

9.4

0.02

(40761536) Microorganisms panel - Urine sediment

227

1631

1.43

5.83

5.6

3.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

184

1270

1.48

5.82

1.5

1.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

341

1.93

5.80

5.8

5.3

umol/l

368.7

364.1

0.09

303

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

548

1.72

5.71

1.3

1.4

g/l

0.3

0.2

0.31

523

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

571

1.71

5.70

1.3

1.4

g/l

1.2

0.16

545

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2013

21008

0.77

5.68

5.8

5.0

mmol/l

2.4

2.8

70.29

1859

19586

(3037756) Immunofixation for Serum or Plasma

402

1.84

5.63

1.6

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

604

7150

0.79

5.59

2.6

2.8

ug/l

0.6

0.7

3.93

428

4480

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

116

2.61

5.55

1.3

1.4

—

(4146454)

243

2.08

5.52

3.4

2.7

—

(3016750) Collection duration of Urine

135

2.46

5.45

2.0

2.2

min

513.8

480.2

0.67

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

329

2542

1.34

5.44

11.8

6.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

857

0.48

5.44

1.7

1.6

—

(3023419) Bacteria identified in Sputum by Culture

286

1.98

5.42

1.8

2.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1560

0.61

5.39

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

112

2.61

5.39

3.4

2.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

199

2.18

5.38

2.6

2.7

u/l

1545.2

2463.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

207

2.15

5.29

2.8

2.6

—

(3013512) EKG study

691

5889

1.24

5.27

4.7

3.8

—

(40768806) Pleura Pathology biopsy report

230

2.06

5.12

1.6

1.5

—

(3025159) Blasts/100 leukocytes in Blood

213

1550

1.41

5.11

3.3

4.6

0.0

0.1

0.69

421

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1908

19991

0.80

5.08

4.7

4.1

mmol/l

1.6

1.4

8.92

1737

18558

(3007463) Buprenorphine [Presence] in Urine

10.03

5.02

4.9

7.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

285

1.91

4.79

1.6

1.5

g/l

34.2

32.7

0.33

254

(3019832) Treponema pallidum Ab [Presence] in Serum

147

1016

1.48

4.67

1.5

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

198

2.09

4.65

1.2

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

544

1.64

4.58

1.2

1.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

135

924

1.49

4.51

2.1

2.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

117

2.41

4.47

1.6

u/l

2.5

5.7

1.14

(3034988) Calcium [Moles/volume] in Capillary blood

3.42

4.46

1.7

1.9

mmol/l

1.2

0.07

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

525

1.64

4.45

1.2

1.9

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2013

19249

1.25

4.39

9.4

5.8

mmol/mol

47.1

40.1

80.86

1897

18007

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

413

1.72

4.36

1.3

1.2

u/ml

333.0

287.3

0.59

264

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.21

4.33

1.5

2.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.89

4.33

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

437

1.69

4.32

1.7

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

437

1.69

4.32

1.3

1.2

—

(4281824)

133

2.27

4.22

1.5

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

328

1.79

4.19

5.0

4.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

497

1.63

4.12

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

119

815

1.48

4.00

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

6.45

3.98

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

637

1.54

3.97

1.6

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

525

4468

1.22

3.92

4.4

4.8

—

(3044889) 12 lead EKG panel

1572

14737

1.18

3.91

4.7

3.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1116

12160

0.85

3.90

4.2

4.4

ug/l

3.8

2.2

0.53

996

11075

(3014271) Vancomycin [Susceptibility]

2.51

3.88

3.0

2.7

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

7.29

3.86

1.1

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

398

1.68

3.83

1.7

1.5

u/ml

114.0

115.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

114

2.29

3.78

1.0

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

115

2.27

3.71

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

4.01

3.70

1.6

2.2

ng/l

88.2

171.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

104

2.32

3.59

2.9

4.0

—

(3017569) Oxygen content in Arterial blood

117

2.24

3.57

3.8

2.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

414

1.64

3.57

1.2

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

399

1.65

3.56

1.2

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

221

1.87

3.50

2.2

4.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.34

3.50

1.3

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.34

3.50

1.3

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

260

2073

1.28

3.45

2.1

2.5

ug/g

175.6

166.8

0.14

214

1704

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

349

1.68

3.43

1.2

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

153

2.04

3.40

1.2

—

(3042631) Mycobacterium sp identified in Specimen

312

1.71

3.40

2.4

2.6

—

(3004451) EKG impression Narrative

114

2.20

3.35

1.5

1.3

—

(1002224) Polysomnography panel

1057

0.64

3.30

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.34

3.24

2.3

1.7

—

(40761535) Cells panel - Urine sediment

210

1643

1.30

3.23

4.0

3.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

221

1.82

3.19

1.9

2.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

251

1.77

3.17

1.3

nmol/l

0.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

148

1104

1.36

3.15

3.2

2.9

e6/l

0.3

0.01

143

1084

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

124

2.11

3.14

1.2

u/l

133.8

93.8

0.68

107

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.55

3.12

2.6

2.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

367

1.62

3.11

2.9

—

1832.3

—

(3042733) HLA Ab [Presence] in Serum

105

2.20

3.09

5.2

4.8

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.81

3.08

1.6

2.3

mmol/l

6.5

8.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

307

1.68

3.05

1.2

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.36

2.98

1.2

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

2.36

2.98

1.8

1.2

—

(44806118)

264

1.72

2.96

1.2

1.7

—

(44790048)

264

1.72

2.96

1.2

1.7

—

(44790049)

264

1.72

2.96

1.2

1.7

—

(44790047)

264

1.72

2.96

1.2

1.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

228

1.77

2.91

1.4

1.3

nmol/l

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2162

21028

1.23

2.90

38.2

16.4

mmol/l

138.0

139.7

103.34

2126

20557

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

736

0.60

2.89

1.5

1.8

mg/l

8.6

4.9

0.46

527

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

229

1.76

2.87

1.4

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

313

1.64

2.85

1.2

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

522

1.49

2.81

1.6

e6/l

16280.9

13531.7

0.27

385

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.06

2.80

1.2

1.3

mmol/l

0.5

1.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

3.06

2.80

1.9

mmol/l

1.2

0.04

(3003338) MCHC [Mass/volume]

1669

17439

0.87

2.79

39.7

17.8

g/l

333.7

334.3

2.15

1654

17330

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

361

3060

1.21

2.78

1.3

iu/ml

32.3

33.8

0.07

955

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

598

1.45

2.77

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

808

7335

1.15

2.71

4.8

3.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.43

2.71

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.13

2.64

1.3

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

352

1.58

2.63

1.2

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

222

1.72

2.58

1.3

2.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

575

1.44

2.55

1.3

1.2

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

5.46

2.54

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.51

2.53

1.2

ug/l

21.1

51.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.28

2.51

1.3

1.1

miu/ml

1427.3

1528.3

0.14

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.83

2.47

5.3

4.8

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.83

2.47

9.6

11.0

mmol/l

4.8

6.4

1.20

(3036525) Urea [Moles/time] in 24 hour Urine

4.38

2.47

2.3

4.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

400

1.51

2.42

1.3

2.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

328

1.57

2.41

1.2

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

450

1.48

2.39

1.5

2.4

—

(3011985) Renin [Units/volume] in Plasma

266

1.63

2.38

1.2

1.4

mu/l

68.6

60.4

0.13

242

(3017937) Magnesium [Moles/time] in 24 hour Urine

6.26

2.37

1.4

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.64

2.36

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

213

1.70

2.36

1.3

1.4

e6/l

201643.8

80150.5

0.59

152

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.10

2.32

1.1

1.0

—

(40768443) Skin Pathology biopsy report

113

852

1.34

2.32

1.1

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

412

1.49

2.32

3.3

4.0

58.8

57.8

0.28

412

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

470

1.46

2.31

1.2

1.4

e6/l

100.5

1022.2

1.44

381

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

470

1.46

2.31

1.1

1.4

e6/l

16.1

26.1

0.24

365

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

332

1.55

2.30

1.2

1.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

192

1.73

2.30

2.3

2.1

g/24h

2.2

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

193

1.72

2.26

1.3

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

193

1.72

2.26

1.3

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

193

1.72

2.26

1.3

1.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

201

1.70

2.25

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2162

21117

1.20

2.24

38.1

16.6

mmol/l

4.0

0.84

2125

20621

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.56

2.21

5.4

7.8

—

(3002385) Erythrocyte distribution width [Ratio]

1737

16700

1.14

2.21

35.8

17.3

14.1

13.7

27.82

1713

16340

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

100

2.01

2.20

1.8

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

2.63

2.18

1.9

2.2

—

(3028717) Thiamine [Mass/volume] in Blood

3.34

2.18

1.0

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

371

1.49

2.13

1.3

2.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

243

1.61

2.13

1.1

1.6

—

(3037121) Protein [Mass/volume] in Urine

717

1.35

2.12

3.4

g/l

0.5

0.3

1.34

346

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

252

1.60

2.10

1.2

1.4

pmol/l

314.9

268.2

0.30

195

(3000034) Microalbumin [Mass/volume] in Urine

221

1.64

2.09

4.0

3.2

mg/l

83.8

72.5

0.07

171

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

489

1.42

2.09

6.3

6.7

iu/ml

389.7

751.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

198

1.68

2.08

1.1

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

398

1.47

2.08

3.3

3.6

e9/l

4.6

4.4

0.33

398

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

231

1.61

2.02

1.2

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

239

1.60

2.01

1.3

1.9

—

(3000492) Spirometry study

259

2199

1.20

2.00

1.4

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

104

1.93

2.00

1.3

1.5

—

(3002619) Bacteria identified in Specimen by Culture

2.82

2.00

1.4

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

233

1.60

1.96

1.2

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

233

1.60

1.96

1.2

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

241

1.59

1.96

1.2

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

134

1.80

1.95

1.5

1.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

164

1.72

1.94

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.55

1.94

12.4

3.9

—

(3035880) pH of Pleural fluid

120

1.84

1.92

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

180

1.67

1.92

1.2

1.8

—

(3044290) Cell count panel - Cerebral spinal fluid

422

1.43

1.91

1.2

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

150

1.74

1.90

1.5

1.4

u/l

24.7

23.3

0.09

114

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

115

899

1.29

1.89

2.9

3.6

pmol/l

4.2

4.5

2.01

100

811

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

228

1.59

1.87

1.2

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

228

1.59

1.87

1.2

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

2.31

1.87

1.1

1.3

110.8

107.7

0.13

(3022145) Colonoscopy Study observation

263

2252

1.19

1.86

1.3

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.09

1.86

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

221

1.59

1.85

1.2

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

229

1.58

1.84

1.2

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

116

912

1.29

1.83

1.6

1.9

u/l

44.4

38.8

1.74

108

803

(3044927) Protein electrophoresis panel - Urine

206

1.61

1.83

1.0

1.1

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

116

1.82

1.78

9.8

11.5

mmol/l

0.6

0.12

107

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

109

1.84

1.77

1.1

—

(3047189) Immunofixation for 24 hour Urine

102

1.87

1.76

1.6

1.9

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.90

1.75

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.90

1.75

1.4

1.5

—

(3000012) Reticulocyte production index

1.88

1.70

1.2

1.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.30

1.70

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.01

1.69

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.19

1.67

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

121

1.74

1.58

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.21

1.57

1.4

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.21

1.57

1.2

1.1

—

(3022621) pH of Urine by Test strip

141

1159

1.23

1.56

2.8

2.6

—

(3002256) Pathology report gross observation

282

2468

1.16

1.56

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.89

1.55

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.89

1.55

3.1

2.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

3.34

1.52

1.0

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.60

1.51

1.1

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.86

1.50

1.0

1.2

—

(3044941) Cell count panel - Synovial fluid

342

1.41

1.49

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.44

1.48

1.0

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.50

1.45

1.0

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.12

1.44

1.2

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

3.13

1.44

1.0

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.92

1.43

7.1

7.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

261

1.46

1.43

1.4

1.6

64.3

58.9

0.32

174

(3021387) Prolactin [Units/volume] in Serum or Plasma

510

1.32

1.40

1.5

1.6

mu/l

424.2

278.1

0.93

478

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.25

1.40

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

222

1.49

1.38

1.1

1.2

—

(3021788) Differential panel - Synovial fluid

390

1.37

1.38

1.4

1.5

—

(3017509) Phencyclidine [Presence] in Urine

2.61

1.36

2.3

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

265

1.44

1.34

1.3

1.9

—

(40768800) Prostate Pathology biopsy report

730

0.75

1.34

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.13

1.33

3.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

299

1.41

1.33

2.5

3.0

nmol/l

0.9

0.19

225

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.78

1.28

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

114

1.67

1.28

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

114

1.67

1.28

2.1

3.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

405

1.34

1.27

1.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

2.29

1.26

1.0

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

227

1.46

1.26

2.2

2.4

—

(3028433) Virus identified in Specimen by Culture

1.86

1.24

1.4

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

212

1.47

1.23

1.4

1.5

18.9

28.8

1.11

140

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

108

1.67

1.22

1.1

1.2

ratio

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.97

1.22

1.2

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.63

1.21

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

132

1.60

1.20

1.2

1.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2160

21900

0.89

1.17

19.7

10.4

u/l

31.3

30.2

1.48

2125

21222

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

322

0.65

1.17

1.1

1.4

pmol/l

165.5

160.3

—

103

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

319

2877

1.12

1.17

1.2

1.3

u/ml

3.9

12.5

2.47

106

1159

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

126

0.47

1.16

1.2

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

447

1.30

1.15

1.2

—

(3025315) Body weight

2.50

1.15

4.4

2.4

—

(4094501)

700

0.77

1.15

1.1

—

(3036603) Volume of Urine

118

1.61

1.14

1.7

1.6

2085.7

1777.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

152

0.52

1.14

1.3

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

115

962

1.20

1.14

1.1

1.2

iu/ml

77.4

144.3

2.18

341

(40757373) Influenza virus identified in Isolate

2.00

1.12

1.3

1.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.00

1.12

1.5

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

310

1.36

1.12

1.1

—

(40768441) Liver Pathology biopsy report

159

1.51

1.12

1.5

1.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

192

1.46

1.11

1.4

1.9

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

612

1.25

1.09

1.6

iu/ml

0.5

10.4

0.48

118

(3013139) Helicobacter pylori Ag [Presence] in Stool

135

1153

1.18

1.08

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

121

1.57

1.05

3.2

2.5

—

(4035726)

193

1699

1.15

1.05

1.4

—

(3022689) Creatine [Moles/volume] in Urine

1.79

1.04

2.6

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

240

0.62

1.03

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

732

0.79

1.03

1.6

1.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1956

19900

0.92

1.00

5.8

4.6

mmol/l

7.1

6.0

52.51

1784

18344

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

132

1.52

0.97

1.2

1.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.74

0.96

7.3

7.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

364

1.30

0.94

1.7

1.8

iu/l

166.3

5.3

0.47

127

(3049717) Cytology report of Urine Cyto stain

108

918

1.18

0.94

2.6

2.7

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

234

1.37

0.93

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.22

0.93

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.73

0.92

1.2

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.73

0.92

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.15

0.91

1.2

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.15

0.91

1.2

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

206

0.63

0.89

1.0

u/ml

2.1

3.0

—

(3048879) Bone marrow aspiration report

1.79

0.87

1.0

2.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.86

0.87

1.1

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

276

0.69

0.87

1.0

1.1

u/ml

0.9

5.9

—

126

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

310

0.71

0.85

1.0

1.1

u/ml

1.7

2.4

—

126

(3024932) HLA-DR beta [Type]

1.57

0.84

1.1

—

(4027681)

121

1.49

0.82

1.4

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.55

0.81

1.1

1.2

iu/ml

400.6

192.8

0.43

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

260

0.69

0.81

1.5

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

356

1.27

0.80

2.3

3.9

1.5

0.03

282

(3045424) Erythrocytes [Presence] in Urine

351

0.74

0.79

2.1

1.4

—

(4212803)

0.00

0.79

0.0

1.1

—

(3017732) Neutrophils [#/volume] in Blood

151

1339

1.14

0.79

3.3

e9/l

4.7

4.1

1.25

111

1066

(21494434) Karyotype in Bone marrow

190

1.37

0.79

1.0

1.3

—

(3024471) HLA-A [Type]

1.53

0.78

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.70

0.75

1.1

1.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.09

0.74

1.0

1.4

umol/24h

1.2

2.0

—

(3050794) Legionella sp Ab [Presence] in Serum

2.09

0.74

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

243

0.70

0.74

1.4

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.00

0.72

2.2

2.8

u/field

0.6

0.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

109

1.47

0.71

1.0

1.1

u/l

1.0

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

181

0.66

0.69

1.4

1.5

g/l

1.1

1.0

0.28

181

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

152

1.38

0.69

1.2

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

401

1.23

0.68

2.3

2.1

—

(3016018) Differential panel - Cerebral spinal fluid

223

1.30

0.66

1.2

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.79

0.66

1.4

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

1841

18685

0.94

0.66

32.6

14.9

38.2

41.1

30.40

1205

13799

(3005570) Glucose [Moles/volume] in Urine

180

1.34

0.65

1.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.73

0.64

1.4

1.2

—

(3017704) Immunofixation for Urine

121

1.41

0.62

1.0

1.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

3.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

266

0.75

0.59

1.0

1.1

u/ml

0.2

0.9

—

100

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.59

0.0

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.59

0.0

3.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.59

0.0

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.45

0.59

1.0

1.5

—

8.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.58

0.0

1.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

211

1.28

0.57

2.7

4.0

56.7

56.5

0.02

137

(44806420)

1.46

0.56

1.8

2.4

—

(3024869) Neuronal Ab [Presence] in Serum

1.62

0.55

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.47

0.54

1.2

1.3

—

(3023410) Appearance of Cerebral spinal fluid

213

1.27

0.54

1.3

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

151

1.33

0.54

1.1

mg/l

260.0

325.4

1.05

132

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.48

0.53

1.7

1.3

ug/l

11.7

8.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

109

1.38

0.51

1.2

1.3

—

275.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

144

1.32

0.50

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.56

0.49

1.0

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

154

1.30

0.48

1.2

1.1

mg/l

39.1

46.4

0.69

127

(3009214) Lutropin [Units/volume] in Serum or Plasma

606

1.14

0.48

1.2

1.4

u/l

8.6

6.5

0.84

491

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

143

0.70

0.47

1.1

1.3

—

(3020491) Glucose [Moles/volume] in Blood

146

1.30

0.47

2.3

2.1

mmol/l

7.6

7.1

0.26

(3043410) Blood group antigens tested for on Red Blood Cells

1.47

0.47

2.0

—

(3008898) HLA-B27 [Presence]

622

0.87

0.46

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

288

2720

1.07

0.46

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

156

1.28

0.45

1.1

—

96.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

242

0.78

0.44

4.7

2.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

253

0.79

0.44

1.2

mmol/l

9.4

7.4

0.85

194

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

202

1.24

0.43

1.1

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

457

0.85

0.42

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.36

0.41

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.52

0.41

11.4

8.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(3013762) Body weight Measured

0.00

0.41

0.0

1.3

—

(3019174) dRVVT (LA screen)

0.00

0.41

0.0

1.2

—

(4015189)

1.36

0.41

1.5

2.6

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.0

—

(3000285) Sodium [Moles/volume] in Blood

1.47

0.40

1.2

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.47

0.40

1.0

1.5

nmol/l

3.0

692599.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

150

1.27

0.40

1.6

2.0

u/field

2.5

2.1

0.13

(3026470) Cobalt [Mass/volume] in Blood

149

0.74

0.40

1.6

2.1

ug/l

2.3

3.3

0.71

129

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.31

0.39

1.1

—

(3024263) Appearance of Synovial fluid

133

1.28

0.38

1.4

1.5

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.39

0.38

1.0

1.3

—

183.0

—

(40768793) Breast Pathology biopsy report

203

0.79

0.38

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

107

1.31

0.37

1.5

2.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

107

1.31

0.37

1.5

2.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

107

1.31

0.37

1.5

2.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

107

1.31

0.37

1.5

2.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

246

0.81

0.37

1.0

1.1

u/ml

2.4

2.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.65

0.35

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.62

0.35

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.40

0.35

1.2

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

222

0.81

0.34

1.0

1.1

u/ml

2.9

1.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

528

5119

1.04

0.33

4.2

3.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

567

1.11

0.33

1.5

1.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

133

0.75

0.33

1.0

2.7

e9/l

0.2

—

119

(3045142) Bone marrow Pathology biopsy report

242

0.82

0.32

1.3

1.4

—

(40761511) CBC panel - Blood by Automated count

2105

21181

0.96

0.32

28.2

13.3

—

(3004616) Nuclear Ab [Presence] in Serum

229

1.18

0.32

1.3

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.33

0.32

1.5

2.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.33

0.32

1.5

2.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

124

1326

0.93

0.31

2.2

2.4

au/ml

11.6

22.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

230

1.18

0.31

2.7

2.4

mg/l

20.8

20.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

474

0.88

0.31

1.4

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

207

0.82

0.30

1.1

1.2

—

39.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

120

1.25

0.30

1.1

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.31

0.30

1.5

2.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

259

1.16

0.29

1.3

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.23

0.29

8.7

7.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

872

1.08

0.29

1.7

2.0

pmol/l

205.1

209.1

0.15

822

(4306422)

326

1.14

0.28

1.3

1.2

—

(40768804) Tissue Pathology biopsy report

768

7523

1.03

0.28

2.1

—

(40768795) Lymph node Pathology biopsy report

194

0.82

0.27

1.1

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.25

0.27

1.0

1.3

—

19.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1198

12144

0.97

0.27

2.9

2.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

271

1.15

0.27

1.1

—

(3011412) CD3 cells [#/volume] in Blood

204

0.83

0.27

1.4

2.4

e9/l

1.1

1.0

0.01

116

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.68

0.26

2.8

2.6

ug/l

3.4

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.23

0.25

1.1

1.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

123

1.22

0.25

24.8

25.7

ug/l

112.2

121.6

—

(3006462) Nitrate [Presence] in Urine

1.22

0.25

2.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

360

1.11

0.23

1.2

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

107

1134

0.94

0.23

1.3

u/ml

698.2

267.6

0.95

101

1044

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

143

1.19

0.23

1.1

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

323

1.12

0.22

1.1

1.2

u/ml

1.6

3.2

1.33

114

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.25

0.22

1.0

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

109

1152

0.94

0.22

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

420

0.90

0.22

5.1

3.4

mg/l

30.8

27.0

0.22

251

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.22

0.22

4.0

3.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.19

0.21

1.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.3

—

(4038314)

0.00

0.21

0.0

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.21

0.0

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.2

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.3

—

653.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

3.1

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

450

0.91

0.21

4.7

4.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

344

1.11

0.21

1.9

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

154

1.17

0.21

1.1

—

79.3

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.5

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

5.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

313

0.89

0.20

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

111

0.81

0.20

1.1

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

577

1.08

0.20

1.8

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

146

1.17

0.19

1.1

—

5.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

154

0.84

0.19

1.5

2.2

73.5

71.3

0.29

146

(3020650) Glucose [Presence] in Urine

1.11

0.17

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

186

1.13

0.17

1.3

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.16

0.16

1.0

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.20

0.16

1.3

1.4

ug/l

17.0

8.4

0.70

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

151

0.86

0.15

1.4

2.2

21.0

15.9

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

111

1.17

0.15

2.4

2.7

u/ml

564.2

1049.9

1.14

111

(4034850)

656

0.94

0.15

19.6

9.1

—

(4211845)

1.08

0.14

2.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.81

0.14

1.0

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

150

1.13

0.14

2.6

1.5

—

74.9

—

(3051593) INR in Capillary blood by Coagulation assay

1.19

0.14

8.5

11.9

—

(3002523) Influenza virus A Ag [Presence] in Specimen

313

0.93

0.12

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

126

0.87

0.11

1.0

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

126

0.87

0.11

1.0

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

157

0.89

0.11

1.5

1.9

mg/l

5.5

4.6

0.27

152

(3023323) Follitropin [Units/volume] in Serum or Plasma

437

1.05

0.10

1.3

1.4

iu/l

21.4

26.5

0.71

367

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.11

0.09

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.09

0.09

1.0

1.1

—

3.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

783

1.04

0.09

1.1

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

1.03

0.08

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

318

0.94

0.08

1.2

u/ml

4.1

5.0

0.20

148

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

0.83

0.08

1.2

2.2

ug/l

45.5

50.7

—

(3006245) CD3-CD19+ cells/100 cells in Blood

0.81

0.08

1.0

2.4

7.8

9.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.84

0.07

1.0

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.82

0.07

1.0

2.9

—

(4268621)

215

1.07

0.07

2.0

2.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

137

1.10

0.07

1.5

1.6

nmol/l

0.1

0.2

—

104

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

245

0.94

0.07

1.0

u/ml

5.4

2.7

—

113

(21494814) CD8 cells/100 lymphocytes in Specimen

0.86

0.06

1.6

2.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

295

0.95

0.06

1.3

1.2

—

(3000330) Specific gravity of Urine by Test strip

900

1.02

0.05

3.6

3.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

141

0.92

0.05

1.5

2.2

—

(3045414) Leukocytes [Presence] in Urine

848

0.98

0.05

2.3

1.8

—

(44813793)

110

0.91

0.05

1.1

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

327

1.04

0.05

1.1

—

(4024509)

150

1.07

0.04

1.6

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1945

19473

0.99

0.03

28.0

13.3

ml/min/173m2

85.5

82.4

6.51

1680

16257

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

131

1.07

0.03

1.5

1.3

u/ml

4.9

0.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

198

0.96

0.02

1.9

2.2

—

42.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

250

2512

0.99

0.02

5.1

4.4

31.4

30.8

0.27

185

1759

(3017446) Testosterone [Moles/volume] in Serum or Plasma

283

2819

1.00

0.01

2.2

2.3

nmol/l

13.7

13.8

0.08

236

2530

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

174

1.03

0.00

1.5

2.4

e6/l

533.6

630.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

215

2143

1.00

0.00

1.4

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

143

0.98

0.00

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

143

0.98

0.00

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

143

0.98

0.00

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

190

1.00

0.00

1.2

—

(3003694) ABO and Rh group [Type] in Blood

553

5527

1.00

0.00

1.5

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

435

1.01

0.00

1.1

1.3

miu/ml

174.6

198.3

0.22

182

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

140

1.00

0.00

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

140

1.00

0.00

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

140

1.00

0.00

1.0

1.1

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.0

—

44.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.92

0.00

1.5

1.6

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

2.4

—

52.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.93

0.00

4.6

7.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

0.98

0.00

1.0

2.3

33.2

30.8

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

1.7

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

38.8

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

8.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.97

0.00

1.7

1.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.00

0.00

1.7

2.3

ug/l

24.4

107.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.98

0.00

3.0

3.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.0

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.00

0.00

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

0.90

0.00

2.4

1.8

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

0.95

0.00

2.0

1.9

—

(3034426) Prothrombin time (PT)

0.95

0.00

1.1

1.3

—

(4133840)

0.96

0.00

1.1

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.2

—

0.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

1.6

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.90

0.00

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.94

0.00

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.00

0.00

1.3

1.7

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint ALCOPANCCHRON and mortality.

Females

Parameter	HR [95% CI]	p-value
ALCOPANCCHRON	4.813 [4.18, 5.54]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.086

During the follow-up period (1.1.1998 — 31.12.2019), 1169 out of 3550 females with ALCOPANCCHRON died.

Males

Parameter	HR [95% CI]	p-value
ALCOPANCCHRON	4.315 [3.99, 4.66]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 5723 out of 15453 males with ALCOPANCCHRON died.

Mortality risk

Mortality risk for people of age

years, who have ALCOPANCCHRON.

N-year risk	Females	Males
1	0.42%	0.927%
5	2.799%	5.219%
10	6.305%	12.083%
15	11.637%	21.346%
20	20.37%	34.41%

Relationships between endpoints

↥

Index endpoint: ALCOPANCCHRON – Alcohol-induced chronic pancreatitis

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Alcohol-induced chronic pancreatitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints